US4559950A - Disposable biomedical and diagnostic electrode - Google Patents

Disposable biomedical and diagnostic electrode Download PDF

Info

Publication number
US4559950A
US4559950A US06/555,071 US55507183A US4559950A US 4559950 A US4559950 A US 4559950A US 55507183 A US55507183 A US 55507183A US 4559950 A US4559950 A US 4559950A
Authority
US
United States
Prior art keywords
conductive
set forth
electrode
gel
adhesive composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US06/555,071
Inventor
Raymond C. Vaughan
David M. DiSabito
Norbert J. Mruk
Arthur R. Eddy, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Graphic Controls Corp
Original Assignee
Graphic Controls Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Graphic Controls Corp filed Critical Graphic Controls Corp
Priority to US06/555,071 priority Critical patent/US4559950A/en
Assigned to GRAPHIC CONTROLS CORPORATION, A CORP OF NY reassignment GRAPHIC CONTROLS CORPORATION, A CORP OF NY ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: DISABITO, DAVID M., EDDY, ARTHUR R. JR, MRUK, NORBERT J., VAUGHAN, RAYMOND C.
Priority to US06/673,552 priority patent/US4588762A/en
Application granted granted Critical
Publication of US4559950A publication Critical patent/US4559950A/en
Assigned to CITIBANK, N.A., reassignment CITIBANK, N.A., SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRAPHIC CONTROLS CORPORATION
Assigned to GRAPHICS CONTROLS CORPORATION, reassignment GRAPHICS CONTROLS CORPORATION, LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: CITIBANK, N.A.,
Assigned to CITICORP INDUSTRIAL CREDIT, INC. reassignment CITICORP INDUSTRIAL CREDIT, INC. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRAPHIC CONTROLS CORPORATION, A NY CORP
Assigned to CITICORP USA, INC. reassignment CITICORP USA, INC. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRAPHIC CONTROLS CORPORATION
Assigned to GRAPHIC CONTROLS CORPORATION reassignment GRAPHIC CONTROLS CORPORATION RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CITIBANK, N.A. 399 PARK AVENUE NEW YORK, NEW YORK 10043
Assigned to CHEMICAL BANK ("COLLATERAL AGENT") reassignment CHEMICAL BANK ("COLLATERAL AGENT") SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRAPHIC CONTROLS CORPORATION
Assigned to GRAPHIC CONTROLS CORPORATION reassignment GRAPHIC CONTROLS CORPORATION RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CITICORP USA, INC.
Assigned to CHEMICAL BANK (AS COLLATERAL AGENT) reassignment CHEMICAL BANK (AS COLLATERAL AGENT) SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRAPHIC CONTROLS CORPORATION
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/251Means for maintaining electrode contact with the body
    • A61B5/256Wearable electrodes, e.g. having straps or bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/251Means for maintaining electrode contact with the body
    • A61B5/257Means for maintaining electrode contact with the body using adhesive means, e.g. adhesive pads or tapes

Definitions

  • This invention relates to single-use, disposable biomedical and diagnostic electrodes of the type used to detect biological or physiological electrical potentials. Such potentials have long been recognized as being derived from or associated with muscular activity.
  • the electrode of the subject invention is characterized by improved electrical contact with the skin to which it is applied, thereby to establish and maintain a desirable low impedance value and to minimize motion artifacts or electrical noise, without the need for gels, except in special cases.
  • ECG electrodes of the disposable type are pregelled, the gel itself being contained in a cavity which is often filled with a porous, gel-retaining sponge-like element. While many improvements have been made in various facets of disposable electrodes in recent years, the products available still harbor objectionable features and fall short of fully satisfying the demanding technical requirements and the need for consistently reliable performance. It is, therefore, a principal aim of the present invention to provide an improved disposable electrode which obviates many of the shortcomings of the prior art devices and provides an improved single-use electrode which is of low cost in production so as to be conveniently and economically disposable and which, at the same time, satisfies the demanding standards of function and reliability.
  • the present invention relates to a biomedical electrode with improved means for effective electric contact between the electrode and a body surface ensuring high fidelity signal transduction, negligible electrical drift, a minimization of polarization and distortion, and an avoidance of artifacts or noise in the recordings or records produced during use of the electrode.
  • the electrode is particularly suitable for detecting and monitoring low-level electrical signals, the reliability being enhanced by an improved mode of securement of the electrode in place, and by improved electrical contact effected between the electrode itself and the skin surface.
  • An additional important feature of the improved electrode structure of the invention is that conductive skin contact is selectively enhanced, when necessary, by application of a conductive gel, the latter being contained in and releasable from a storage cavity in the electrode itself.
  • a related feature of the electrode of the invention is that there is provided a pressure releasable gel which establishes a fluid film interface bridging between the patient's skin and the conductive adhesive and, concurrently, provides a highly conductive path between the electrode lead line and the patient's skin.
  • the gel serves as a stabilizing factor for the adhesive by serving as a humidifier for the adhesive.
  • a general feature of the invention is that the electrode functions without a gel. Yet a gel is available, at hand, for use in enhancing electrical contact with the patient's skin when such enhancement is found necessary.
  • the electrode is formed to define a storage cavity constituting a reservoir for a gel composition.
  • a selectably actuable port communicating between the gel reservoir and the patient's skin is defined by a pre-cut slit in the skin-presented support band of the electrode.
  • a related feature of the invention is that the pre-cut slit in the support band defines an orifice which is in a normally closed or standby mode.
  • the support band is responsive to fluid pressure applied thereagainst to open the slit and to promote gel flow or passage therethrough, from the reservoir cavity, thereby to provide an enhanced electrically conductive path between the conductor lead line of the electrode and an electrode-delineated body zone to which the electrode is adhered.
  • the conductivity of the conductive adhesive is enhanced through the incorporation of electrically conductive particles distributed throughout the adhesive composition.
  • a principal feature of a preferred embodiment of the electrode of the invention is the use of a conductive adhesive which, in a preferred embodiment of the invention, includes salts dispersed therethrough for rendering the adhesive ionically conductive.
  • a related feature of the conductive adhesive of the invention is that conductive particles contained therein and distributed therethrough constitute carbon particles.
  • the conductivity properties are enhanced through the incorporation of metallic particles, and in an alternative embodiment, electrical conductivity of the conductive adhesive is enhanced through the incorporation of conductively coated glass spheres or other inert particles.
  • the optional release and use of the conductive gel is effected at the time the electrode is adhesively bonded to the skin surface.
  • FIG. 1 is a top plan view of an electrode according to the invention, incorporating the features thereof;
  • FIG. 2 is a cross sectional view taken substantially on the lines 2--2 of FIG. 1;
  • FIG. 3 is an expanded view showing the relative arrangement of the various stacked components of the electrode of the invention.
  • FIG. 4 is an exploded perspective showing the component elements of the electrode of the invention.
  • FIG. 5 is a cross-sectional view of an alternative form of an element of the electrode structure of the invention.
  • the aims and objects of the invention are achieved by providing in a disposable biomedical and diagnostic electrode conductive adhesive electrical contact and an optionally usable gel reservoir. Electrical connection and continuity are achieved by means of a conductive adhesive which constitutes a bonding interface interposed between an undersurface of the electrode and the body zone to which the electrode is applied in use.
  • the conductive adhesive is in electrically conductive contact with a conductive element of the electrode to which a lead line may be attached.
  • the electrode of the invention is further characterized in that there is provided a conductive gel reservoir, and in that a selectively actuable port defines passage means communicating between the gel storage reservoir or cavity and the conductive adhesive surface and the skin zone to which the electrode is adhered.
  • finger pressure selectively transmitted to the gel contained in the reservoir forces the gel through the port and establishes a film interface between the patient's skin and the conductive adhesive and, concurrently, provides an enhanced conductive path between the electrode itself and the patient's skin.
  • the single-use disposable electrode consists of a multi-layer, mult-component structure supported on a peelable release liner 24.
  • the release liner 24 may be a silicone-treated sheet of paper, a plastic film, or other type of release liner as known in the art.
  • a conductive strip 28 with a conductive adhesive 32 applied to its under surface is releasably adhered to the release liner 24.
  • the conductive strip 28 may be a strip of metal or of other selectable conductive materials.
  • the conductive strip 28 comprises a conductive chemical composition 30 applied to a flexible plastic support band or ribbon 29, as shown in FIG. 3.
  • the support band 29 may be a sheet of MYLAR polyester, for example, while the conductive chemical composition 30 may be a metallic ink such as a silver ink.
  • the surface of the conductive chemical composition 30 may be chloridized as known in the art in order to improve the electrochemical reversibility of the electrode 20.
  • a snap fastener stud 38 and eyelet 40 for the convenient snap-on attachment of a lead line (not shown) during electrode use.
  • a lead line may be secured through other expedients, for example, by attachment of a clamping clip to the projecting end portion 36 of the strip 28.
  • a tab 42 of plastic or similar non-conductive material is secured on the undersurface of the strip 28 to project beyond the end of the strip 28 and to serve as an insulating shield between the electrical clip (not shown) and the patient's body.
  • the electrically conductive strip 28 is provided with a die-cut slit 46 which in an undisturbed state is essentially "closed".
  • the slit 46 illustrated schematically, is best seen in the exploded perspective of FIG. 4. Holes may be substituted for the slit.
  • a cushion-like wafer or washer-like disk 50 of a relatively soft and compressible, inert foamed plastic Superimposed on and bonded to and overlying the strip 28 is a cushion-like wafer or washer-like disk 50 of a relatively soft and compressible, inert foamed plastic.
  • the disk 50 is formed with a circular cut-out area 52 and, in the positioning of the disk 50 with respect to the strip 28, an in-line axial registration is established between the cut-out area 52 of the disk 50 and the slit 46 in the strip 28 therebelow (FIG. 2). It will be appreciated that in the structure described, there is provided a cavity which is defined by the cut-out 52 in the disk 50 and which is closed at its base by the strip 28.
  • the open-top cavity is filled with a conductive gel 60.
  • a conductive gel 60 Many suitable conductive gel compositions are known in the art, and the specific composition of the gel itself is not critical in the practice of the present invention.
  • the gel should contain a substantial concentration of a humectant, for example, at least about 50% by weight of glycerol.
  • the underface of the disk to is coated with an adhesive composition 62 so that, in assembly, the disk 50 is secured not only to the strip 28 but also to the peelable release liner 24 therebelow and extending laterally thereabout.
  • the open top of the cavity 52 is closed or sealed by means of a plastic cover 64 which is coated on its underside with an adhesive 66, so that the closure 64 is securely bonded and sealed to the top surface 70 of the foam washer 50.
  • the electrode 20 assumes the structure illustrated schematically in FIG. 2.
  • the electrode is applied to the selected skin surface zone by a conventional procedure.
  • the conductive surface may be established by applying a metal-containing ink formulation.
  • a metal-containing ink formulation various formulations of conductive adhesives may be used in the practice of the present invention. None of these formulations constitutes, per se, an element of the present invention.
  • the principal mode of electrical transmission through the conductive adhesive will be by ions rather than by electrons, and the thickness of the conductive adhesive layer 32 will be small, preferably less than 10 mils. Ionic conductivity provides superior electrochemical reversibility and hence superior signal transmission fidelity in a biomedical electrode, while thinness of the conductive adhesive layer allows the conductive adhesive layer to conform to the skin, thus maintaining uniform electrical properties.
  • Such adhesives may be enhanced through the incorporation of fillers including salts or electrically conductive particles.
  • Such particles may be metallic particles, or, alternatively, carbon particles, or other inert particles, or glass coated with suitable conductive materials. While preferred embodiments of the invention have been illustrated, other variations may be made utilizing the inventive concepts herein disclosed. It is intended that all such variations in functional structures and in compositions be considered as within the scope of the invention as defined in the following claims.

Abstract

A disposable biomedical and diagnostic electrode characterized in that functional electrical contact is effected between the skin and an electrically conductive element of the electrode by means of a conductive adhesive, and in that conductive skin contact is enhanced, when necessary, by selective application of a conductive gel contained in and releasable from a storage cavity in the electrode itself. The pressure-released gel establishes a fluid film interface between the patient's skin and the conductive adhesive and, concurrently, provides a highly conductive path between the electrode itself, and the patient's skin.

Description

BACKGROUND OF THE INVENTION
This invention relates to single-use, disposable biomedical and diagnostic electrodes of the type used to detect biological or physiological electrical potentials. Such potentials have long been recognized as being derived from or associated with muscular activity. The electrode of the subject invention is characterized by improved electrical contact with the skin to which it is applied, thereby to establish and maintain a desirable low impedance value and to minimize motion artifacts or electrical noise, without the need for gels, except in special cases.
Many of the electrodes in common use utilize adhesives as means for bonding and securing the electrode in place. For the most part, ECG electrodes of the disposable type are pregelled, the gel itself being contained in a cavity which is often filled with a porous, gel-retaining sponge-like element. While many improvements have been made in various facets of disposable electrodes in recent years, the products available still harbor objectionable features and fall short of fully satisfying the demanding technical requirements and the need for consistently reliable performance. It is, therefore, a principal aim of the present invention to provide an improved disposable electrode which obviates many of the shortcomings of the prior art devices and provides an improved single-use electrode which is of low cost in production so as to be conveniently and economically disposable and which, at the same time, satisfies the demanding standards of function and reliability.
SUMMARY OF THE INVENTION
The present invention relates to a biomedical electrode with improved means for effective electric contact between the electrode and a body surface ensuring high fidelity signal transduction, negligible electrical drift, a minimization of polarization and distortion, and an avoidance of artifacts or noise in the recordings or records produced during use of the electrode. The electrode is particularly suitable for detecting and monitoring low-level electrical signals, the reliability being enhanced by an improved mode of securement of the electrode in place, and by improved electrical contact effected between the electrode itself and the skin surface.
It is an important feature of the electrode of the invention that functional electrical contact is effected between the skin and an electrically conductive element of the electrode by means of a conductive, skin-contacting adhesive.
An additional important feature of the improved electrode structure of the invention is that conductive skin contact is selectively enhanced, when necessary, by application of a conductive gel, the latter being contained in and releasable from a storage cavity in the electrode itself.
A related feature of the electrode of the invention is that there is provided a pressure releasable gel which establishes a fluid film interface bridging between the patient's skin and the conductive adhesive and, concurrently, provides a highly conductive path between the electrode lead line and the patient's skin.
An additional important feature of the electrode is that the gel serves as a stabilizing factor for the adhesive by serving as a humidifier for the adhesive.
A general feature of the invention is that the electrode functions without a gel. Yet a gel is available, at hand, for use in enhancing electrical contact with the patient's skin when such enhancement is found necessary.
It is an important feature of the present invention that the electrode is formed to define a storage cavity constituting a reservoir for a gel composition. A selectably actuable port communicating between the gel reservoir and the patient's skin is defined by a pre-cut slit in the skin-presented support band of the electrode.
A related feature of the invention is that the pre-cut slit in the support band defines an orifice which is in a normally closed or standby mode. The support band is responsive to fluid pressure applied thereagainst to open the slit and to promote gel flow or passage therethrough, from the reservoir cavity, thereby to provide an enhanced electrically conductive path between the conductor lead line of the electrode and an electrode-delineated body zone to which the electrode is adhered.
It is yet another feature of the electrode of the invention that the application of finger pressure to the electrode downwardly thereupon is transmitted to gel in the reservoir cavity and thus impressed against the slit-carrying support band to open the slit and to cause gel to flow therethrough.
It is a feature of the invention that the conductivity of the conductive adhesive is enhanced through the incorporation of electrically conductive particles distributed throughout the adhesive composition.
A principal feature of a preferred embodiment of the electrode of the invention is the use of a conductive adhesive which, in a preferred embodiment of the invention, includes salts dispersed therethrough for rendering the adhesive ionically conductive.
A related feature of the conductive adhesive of the invention is that conductive particles contained therein and distributed therethrough constitute carbon particles.
In still another preferred embodiment of the conductive adhesive of the invention the conductivity properties are enhanced through the incorporation of metallic particles, and in an alternative embodiment, electrical conductivity of the conductive adhesive is enhanced through the incorporation of conductively coated glass spheres or other inert particles.
It is a feature of the electrode of the invention that it may be used, selectively, with and without the release of conductive gel from the storage reservoir.
It is an important practical and utilitarian feature of the improved electrode of the invention that the optional release and use of the conductive gel is effected at the time the electrode is adhesively bonded to the skin surface.
Other and further objects, features, and advantages of the invention will be evident from a reading of the following specification taken in conjunction with the drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a top plan view of an electrode according to the invention, incorporating the features thereof;
FIG. 2 is a cross sectional view taken substantially on the lines 2--2 of FIG. 1;
FIG. 3 is an expanded view showing the relative arrangement of the various stacked components of the electrode of the invention;
FIG. 4 is an exploded perspective showing the component elements of the electrode of the invention; and
FIG. 5 is a cross-sectional view of an alternative form of an element of the electrode structure of the invention.
DESCRIPTION OF PREFERRED EMBODIMENT
The aims and objects of the invention are achieved by providing in a disposable biomedical and diagnostic electrode conductive adhesive electrical contact and an optionally usable gel reservoir. Electrical connection and continuity are achieved by means of a conductive adhesive which constitutes a bonding interface interposed between an undersurface of the electrode and the body zone to which the electrode is applied in use. The conductive adhesive is in electrically conductive contact with a conductive element of the electrode to which a lead line may be attached. The electrode of the invention is further characterized in that there is provided a conductive gel reservoir, and in that a selectively actuable port defines passage means communicating between the gel storage reservoir or cavity and the conductive adhesive surface and the skin zone to which the electrode is adhered. At the direction of the user, finger pressure selectively transmitted to the gel contained in the reservoir forces the gel through the port and establishes a film interface between the patient's skin and the conductive adhesive and, concurrently, provides an enhanced conductive path between the electrode itself and the patient's skin.
Referring now to the drawings, there is shown one preferred embodiment of the electrode 20 of the invention provided for illustrative purposes and not to be construed in any limiting sense. The single-use disposable electrode consists of a multi-layer, mult-component structure supported on a peelable release liner 24. The release liner 24 may be a silicone-treated sheet of paper, a plastic film, or other type of release liner as known in the art. A conductive strip 28 with a conductive adhesive 32 applied to its under surface is releasably adhered to the release liner 24. The conductive strip 28 may be a strip of metal or of other selectable conductive materials. In the preferred embodiment of the invention, however, the conductive strip 28 comprises a conductive chemical composition 30 applied to a flexible plastic support band or ribbon 29, as shown in FIG. 3. The support band 29 may be a sheet of MYLAR polyester, for example, while the conductive chemical composition 30 may be a metallic ink such as a silver ink. If desired, the surface of the conductive chemical composition 30 may be chloridized as known in the art in order to improve the electrochemical reversibility of the electrode 20.
At the end portion 36 of the conductive strip 28, projecting laterally beyond the principal body structure of the electrode itself, there is attached a snap fastener stud 38 and eyelet 40 for the convenient snap-on attachment of a lead line (not shown) during electrode use. A lead line may be secured through other expedients, for example, by attachment of a clamping clip to the projecting end portion 36 of the strip 28. In contemplation of the latter option, a tab 42 of plastic or similar non-conductive material is secured on the undersurface of the strip 28 to project beyond the end of the strip 28 and to serve as an insulating shield between the electrical clip (not shown) and the patient's body.
The electrically conductive strip 28 is provided with a die-cut slit 46 which in an undisturbed state is essentially "closed". The slit 46, illustrated schematically, is best seen in the exploded perspective of FIG. 4. Holes may be substituted for the slit.
Superimposed on and bonded to and overlying the strip 28 is a cushion-like wafer or washer-like disk 50 of a relatively soft and compressible, inert foamed plastic. The disk 50 is formed with a circular cut-out area 52 and, in the positioning of the disk 50 with respect to the strip 28, an in-line axial registration is established between the cut-out area 52 of the disk 50 and the slit 46 in the strip 28 therebelow (FIG. 2). It will be appreciated that in the structure described, there is provided a cavity which is defined by the cut-out 52 in the disk 50 and which is closed at its base by the strip 28.
In accordance with the practice of the invention, the open-top cavity is filled with a conductive gel 60. Many suitable conductive gel compositions are known in the art, and the specific composition of the gel itself is not critical in the practice of the present invention.
However, in preferred embodiments of the invention, the gel should contain a substantial concentration of a humectant, for example, at least about 50% by weight of glycerol.
It should be understood that the underface of the disk to is coated with an adhesive composition 62 so that, in assembly, the disk 50 is secured not only to the strip 28 but also to the peelable release liner 24 therebelow and extending laterally thereabout.
In the specific embodiment of the electrode illustrated, the open top of the cavity 52 is closed or sealed by means of a plastic cover 64 which is coated on its underside with an adhesive 66, so that the closure 64 is securely bonded and sealed to the top surface 70 of the foam washer 50. In its fully assembled form, the electrode 20 assumes the structure illustrated schematically in FIG. 2.
While the above detailed description is directed to one preferred embodiment of the invention, it will be understood that variations involving both structure and composition may be made without departing from the invention itself. For example, it is within the contemplation of the invention that the need for a surmounting cavity seal or special closure 64 may be obviated by adopting a variation in the physical configuration of the cavity-defining pad. As shown (FIG. 5), the foam disk 50a is not cut through in the cavity-defining zone 52a. Rather, a residual surmounting portion 70a of the foam disk 50a defines a top "closure" for the cavity 52a.
It is believed that the method of use of the electrode of the invention will be apparent from the foregoing detailed description. Specifically, the electrode is applied to the selected skin surface zone by a conventional procedure. First, one removes the peelable release liner 24 to expose the adhesive-coated surfaces of the conductive strip 28 and of the foam disk 50. Electrical contact between the skin surface and the conductive strip 28 is established through the conductive adhesive 32, and the electrical circuit between the skin and the snap fastener terminal 38 or the end zone 36 of the strip 28 itself is completed. Should it be deemed necessary or expedient to provide an enhanced electrically conductive path between the conductive strip 28 and the body surface, one need merely press downwardly on the foam pad 50 which houses the reservoir 52 for the conductive gel 60. Pressure so applied to the electrode causes the stored gel 60 to transfer pressure against the strip 28 in that region of the strip which is formed with the slit 46. The applied pressure causes the slit 46 to open and permits the flow of conductive gel 60 therethrough. It is presently contemplated that in the majority of cases, the electrical contact effected through reliance solely on the conductive adhesive 32 will be adequate to ensure the requisite circuit integrity and continuity. Only in a relatively small percentage of uses, for example, where the patient's skin is covered with a substantial concentration of hair fibers will the utilization of the gel be dictated.
In the embodiments of the invention in which the band 28 is a plastic film segment, it is contemplated that the conductive surface may be established by applying a metal-containing ink formulation. It is to be understood that various formulations of conductive adhesives may be used in the practice of the present invention. None of these formulations constitutes, per se, an element of the present invention. In the preferred embodiment of the present invention, however, the principal mode of electrical transmission through the conductive adhesive will be by ions rather than by electrons, and the thickness of the conductive adhesive layer 32 will be small, preferably less than 10 mils. Ionic conductivity provides superior electrochemical reversibility and hence superior signal transmission fidelity in a biomedical electrode, while thinness of the conductive adhesive layer allows the conductive adhesive layer to conform to the skin, thus maintaining uniform electrical properties.
It is contemplated that the conductivity of such adhesives may be enhanced through the incorporation of fillers including salts or electrically conductive particles. Such particles may be metallic particles, or, alternatively, carbon particles, or other inert particles, or glass coated with suitable conductive materials. While preferred embodiments of the invention have been illustrated, other variations may be made utilizing the inventive concepts herein disclosed. It is intended that all such variations in functional structures and in compositions be considered as within the scope of the invention as defined in the following claims.

Claims (19)

What is claimed is:
1. A disposable electrode for medical diagnostic and biomedical use, and for clinical use,
said electrode comprising a composite assembly including:
a support sheet connected to and surmounting said assembly,
said support sheet comprising a wafer-like disk having an underside for application of an adhesive thereon,
said disk being formed with a gel storage cavity defining reservoir means for confining a conductive gel therein,
a conductive gel stored in said reservoir means,
band means bridging said gel storage cavity and serving as a bottom closure for said reservoir means,
said band means having an upper surface presented to said support sheet and a lower surface for securement to a patient's body,
adhesive means bonding said upper surface of said band means to said support sheet on said underside thereof,
a conductive adhesive composition constituting a conductive layer coating said lower surface of said band means for adhesively securing said electrode to a patient's body,
said band means including means in electrically conductive communication with said conductive adhesive composition for attachment of an electrical lead line thereto,
port means including passage-defining means formed in said band means for providing fluid-flow communication between said reservoir means and said conductive adhesive composition for releasing said gel from said reservoir means,
said port means being normally constricted and being selectively actuable to open to release gel from said reservoir means and to provide an enhanced conductive path between said conductive adhesive composition and a body surface to which said electrode is applied.
2. The structure as set forth in claim 1 wherein said support sheet comprises a foamed, soft, plastic disk.
3. The structure as set forth in claim 1 wherein said
port means includes pre-cut slit means in said band means for permitting flow of said gel from said reservoir means.
4. The structure as set forth in claim 3 wherein said slit means is in a normally-closed, stand-by mode, and
wherein said band means is responsive to fluid pressure applied thereagainst to open said slit means and to promote gel flow therethrough from said reservoir means and to provide an enhanced electrically conductive path between said conductive adhesive composition and an electrode-delineated body zone to which said electrode is adhered.
5. The structure as set forth in claim 1 wherein said reservoir means comprises a vertically extending transverse through passage in said support sheet, and further comprising a cover surmounting said passage and bonded to a top surface of said support sheet as a top closure for said reservoir means.
6. The structure as set forth in claim 1 further comprising means for applying finger pressure to said electrode to transfer said gel in said reservoir means and against said port means to open said port means and to cause gel to flow therethrough from said reservoir means.
7. The structure as set forth in claim 1 wherein said band means includes an end portion extension for connecting an electrical lead line to said band means.
8. The structure as set forth in claim 7 and further comprising tab-like insulator means and means securing said insulator means to said electrode on said lower surface of said band means for insulating electrically between said end portion extension of said band means and the body of a wearer of said electrode.
9. The structure as set forth in claim 1 wherein said band means consists essentially of a plastic film segment, and further comprising a conductive coating applied to said plastic film segment as an interface between said film segment and said conductive adhesive composition.
10. The structure as set forth in claim 1 wherein said conductive adhesive composition includes salt means dispersed therethrough for rendering said conductive adhesive composition ionically conductive.
11. The structure as set forth in claim 1 and further comprising filler means including electrically conductive particles distributed throughout said conductive adhesive composition for enhancement of electrical conductive properties thereof.
12. The structure as set forth in claim 1 wherein said means in electrically conductive communication with said conductive adhesive composition includes a snap fastener element.
13. The structure as set forth in claim 11 wherein said electrically conductive particles include metallic particles.
14. The structure as set forth in claim 11 wherein said electrically conductive particles include carbon particles.
15. The structure as set forth in claim 11 wherein said electrically conductive particles include coated glass spheres.
16. The structure as set forth in claim 1 wherein said conductive adhesive composition has a through thickness not exceeding 10 mils.
17. The structure as set forth in claim 9 wherein said conductive coating comprises a silver ink and wherein said conductive coating is chloridized.
18. The structure as set forth in claim 1 wherein said conductive gel contains a humectant, and wherein the concentration of humectant in said conductive gel is at least about 50% by weight.
19. The structure as set forth in claim 1 wherein said band means consists essentially of an electrically conductive metallic strip.
US06/555,071 1983-11-25 1983-11-25 Disposable biomedical and diagnostic electrode Expired - Fee Related US4559950A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US06/555,071 US4559950A (en) 1983-11-25 1983-11-25 Disposable biomedical and diagnostic electrode
US06/673,552 US4588762A (en) 1983-11-25 1984-11-20 Pressure sensitive adhesive compositions for medical electrodes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/555,071 US4559950A (en) 1983-11-25 1983-11-25 Disposable biomedical and diagnostic electrode

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US06/673,552 Continuation-In-Part US4588762A (en) 1983-11-25 1984-11-20 Pressure sensitive adhesive compositions for medical electrodes

Publications (1)

Publication Number Publication Date
US4559950A true US4559950A (en) 1985-12-24

Family

ID=24215850

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/555,071 Expired - Fee Related US4559950A (en) 1983-11-25 1983-11-25 Disposable biomedical and diagnostic electrode

Country Status (1)

Country Link
US (1) US4559950A (en)

Cited By (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284943A1 (en) * 1987-03-30 1988-10-05 Fukuda Denshi Co., Ltd. Multi-electrode type electrocardiographic electrode structure
US5150708A (en) * 1990-12-03 1992-09-29 Spacelabs, Inc. Tabbed defibrillator electrode pad
US5402780A (en) * 1993-09-02 1995-04-04 Faasse, Jr.; Adrian L. Medical electrode with offset contact stud
US5458141A (en) * 1993-08-04 1995-10-17 Quinton Instrument Company Abrasive skin electrode
US5566672A (en) * 1994-01-03 1996-10-22 Labeltape Meditect, Inc. Biomedical electrode
US5645063A (en) * 1995-06-05 1997-07-08 Quinton Instrument Company Skin electrode having multiple conductive center members
WO2000002484A1 (en) * 1998-07-10 2000-01-20 Physiometrix, Inc. Self adjusting headgear appliance using reservoir electrodes
EP1078595A3 (en) * 1999-08-24 2001-03-07 Cas Medical Systems, Inc. Disposable neonatal electrode for use in a high humidity enviroment
US6301493B1 (en) * 1999-07-10 2001-10-09 Physiometrix, Inc. Reservoir electrodes for electroencephalograph headgear appliance
US6526303B1 (en) * 2000-10-27 2003-02-25 Koninklijke Philips Electronics N.V. Disposable defibrillation and external pacing electrode
US20040162602A1 (en) * 2003-02-19 2004-08-19 Shlomi Cohen Surface electrode for electrical stimulation of tissue
US20040249432A1 (en) * 2003-02-19 2004-12-09 Stimu-Heal Inc. Surface electrode for electrical stimulation of tissue
US7069074B2 (en) 2001-11-07 2006-06-27 Medtronic Emergency Response Systems, Inc. Easy-to-use electrode and package
US20060155181A1 (en) * 2002-08-21 2006-07-13 Ruediger Eichler Measuring electrode system
US7978064B2 (en) 2005-04-28 2011-07-12 Proteus Biomedical, Inc. Communication system with partial power source
US8036748B2 (en) 2008-11-13 2011-10-11 Proteus Biomedical, Inc. Ingestible therapy activator system and method
US8054140B2 (en) 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
US8055334B2 (en) 2008-12-11 2011-11-08 Proteus Biomedical, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8114021B2 (en) 2008-12-15 2012-02-14 Proteus Biomedical, Inc. Body-associated receiver and method
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
US8258962B2 (en) 2008-03-05 2012-09-04 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US20120265025A1 (en) * 2011-04-13 2012-10-18 King's Metal Fiber Technologies Co., Ltd. Wearing structure for measuring physiological signal
WO2012140629A1 (en) * 2011-04-15 2012-10-18 Universidade Do Porto Polymer-based electrode for bio-signal recording
US20130023748A1 (en) * 2011-07-11 2013-01-24 Nellcor Puritan Bennett Llc Device with encapsulated gel
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
WO2014025353A1 (en) * 2012-08-09 2014-02-13 Northeastern University Electric field encephalography: electric field based brain signal detection and monitoring
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US10912480B2 (en) 2013-06-21 2021-02-09 Northeastern University Sensor system and process for measuring electric activity of the brain, including electric field encephalography
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US11147465B2 (en) 2015-05-05 2021-10-19 Welch Allyn, Inc. Abrasive electrode
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3977392A (en) * 1975-04-21 1976-08-31 Eastprint, Inc. Medical electrode
US3993049A (en) * 1974-12-26 1976-11-23 Kater John A R Electrodes and materials therefor
US4079731A (en) * 1975-07-03 1978-03-21 Cardiolink Electrodes, Ltd. Medical electrodes
US4098945A (en) * 1973-07-30 1978-07-04 Minnesota Mining And Manufacturing Company Soft conductive materials
US4237886A (en) * 1977-04-02 1980-12-09 Sony Corporation Electrode to be used in contact with a living body
US4270543A (en) * 1978-10-06 1981-06-02 Tdk Electronics Co., Ltd. Silver-silver chloride electrode
US4274420A (en) * 1975-11-25 1981-06-23 Lectec Corporation Monitoring and stimulation electrode
US4318746A (en) * 1980-01-08 1982-03-09 Ipco Corporation Highly stable gel, its use and manufacture
US4367745A (en) * 1980-05-27 1983-01-11 Minnesota Mining And Manufacturing Company Conformable electrically conductive compositions
US4393584A (en) * 1979-12-06 1983-07-19 C. R. Bard, Inc. Method of manufacture of electrode construction
US4419091A (en) * 1981-02-12 1983-12-06 Sybron Corporation Metalized medical treatment electrode with insulated edge

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098945A (en) * 1973-07-30 1978-07-04 Minnesota Mining And Manufacturing Company Soft conductive materials
US3993049A (en) * 1974-12-26 1976-11-23 Kater John A R Electrodes and materials therefor
US3977392A (en) * 1975-04-21 1976-08-31 Eastprint, Inc. Medical electrode
US4079731A (en) * 1975-07-03 1978-03-21 Cardiolink Electrodes, Ltd. Medical electrodes
US4274420A (en) * 1975-11-25 1981-06-23 Lectec Corporation Monitoring and stimulation electrode
US4237886A (en) * 1977-04-02 1980-12-09 Sony Corporation Electrode to be used in contact with a living body
US4270543A (en) * 1978-10-06 1981-06-02 Tdk Electronics Co., Ltd. Silver-silver chloride electrode
US4393584A (en) * 1979-12-06 1983-07-19 C. R. Bard, Inc. Method of manufacture of electrode construction
US4318746A (en) * 1980-01-08 1982-03-09 Ipco Corporation Highly stable gel, its use and manufacture
US4367745A (en) * 1980-05-27 1983-01-11 Minnesota Mining And Manufacturing Company Conformable electrically conductive compositions
US4419091A (en) * 1981-02-12 1983-12-06 Sybron Corporation Metalized medical treatment electrode with insulated edge

Cited By (138)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284943A1 (en) * 1987-03-30 1988-10-05 Fukuda Denshi Co., Ltd. Multi-electrode type electrocardiographic electrode structure
US5150708A (en) * 1990-12-03 1992-09-29 Spacelabs, Inc. Tabbed defibrillator electrode pad
US5458141A (en) * 1993-08-04 1995-10-17 Quinton Instrument Company Abrasive skin electrode
US5402780A (en) * 1993-09-02 1995-04-04 Faasse, Jr.; Adrian L. Medical electrode with offset contact stud
US5566672A (en) * 1994-01-03 1996-10-22 Labeltape Meditect, Inc. Biomedical electrode
US5645063A (en) * 1995-06-05 1997-07-08 Quinton Instrument Company Skin electrode having multiple conductive center members
WO2000002484A1 (en) * 1998-07-10 2000-01-20 Physiometrix, Inc. Self adjusting headgear appliance using reservoir electrodes
US6301493B1 (en) * 1999-07-10 2001-10-09 Physiometrix, Inc. Reservoir electrodes for electroencephalograph headgear appliance
US6687524B1 (en) 1999-08-24 2004-02-03 Cas Medical Systems, Inc Disposable neonatal electrode for use in a high humidity environment
EP1078595A3 (en) * 1999-08-24 2001-03-07 Cas Medical Systems, Inc. Disposable neonatal electrode for use in a high humidity enviroment
US6526303B1 (en) * 2000-10-27 2003-02-25 Koninklijke Philips Electronics N.V. Disposable defibrillation and external pacing electrode
US20060206152A1 (en) * 2001-10-02 2006-09-14 Medtronic Emergency Response Systems, Inc. Easy-to-use electrode and package
US20100063558A9 (en) * 2001-10-02 2010-03-11 Medtronic Emergency Response Systems, Inc. Easy-to-use electrode and package
US7797044B2 (en) 2001-10-02 2010-09-14 Physio-Control, Inc. Easy-to-use electrode and package
US7069074B2 (en) 2001-11-07 2006-06-27 Medtronic Emergency Response Systems, Inc. Easy-to-use electrode and package
US20060155181A1 (en) * 2002-08-21 2006-07-13 Ruediger Eichler Measuring electrode system
US7532921B2 (en) * 2002-08-21 2009-05-12 Ruediger Eichler Measuring electrode system
US20040162602A1 (en) * 2003-02-19 2004-08-19 Shlomi Cohen Surface electrode for electrical stimulation of tissue
US20040249432A1 (en) * 2003-02-19 2004-12-09 Stimu-Heal Inc. Surface electrode for electrical stimulation of tissue
US7043308B2 (en) 2003-02-19 2006-05-09 Stimu-Heal, Inc. Surface electrode for electrical stimulation of tissue
US7177705B2 (en) 2003-02-19 2007-02-13 Stimu-Heal Inc. Surface electrode for electrical stimulation of tissue
US10542909B2 (en) 2005-04-28 2020-01-28 Proteus Digital Health, Inc. Communication system with partial power source
US9161707B2 (en) 2005-04-28 2015-10-20 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US9681842B2 (en) 2005-04-28 2017-06-20 Proteus Digital Health, Inc. Pharma-informatics system
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US9649066B2 (en) 2005-04-28 2017-05-16 Proteus Digital Health, Inc. Communication system with partial power source
US8816847B2 (en) 2005-04-28 2014-08-26 Proteus Digital Health, Inc. Communication system with partial power source
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US11476952B2 (en) 2005-04-28 2022-10-18 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US9962107B2 (en) 2005-04-28 2018-05-08 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8674825B2 (en) 2005-04-28 2014-03-18 Proteus Digital Health, Inc. Pharma-informatics system
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
US9439582B2 (en) 2005-04-28 2016-09-13 Proteus Digital Health, Inc. Communication system with remote activation
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US10517507B2 (en) 2005-04-28 2019-12-31 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US9597010B2 (en) 2005-04-28 2017-03-21 Proteus Digital Health, Inc. Communication system using an implantable device
US10610128B2 (en) 2005-04-28 2020-04-07 Proteus Digital Health, Inc. Pharma-informatics system
US7978064B2 (en) 2005-04-28 2011-07-12 Proteus Biomedical, Inc. Communication system with partial power source
US9119554B2 (en) 2005-04-28 2015-09-01 Proteus Digital Health, Inc. Pharma-informatics system
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US11928614B2 (en) 2006-05-02 2024-03-12 Otsuka Pharmaceutical Co., Ltd. Patient customized therapeutic regimens
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US8054140B2 (en) 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
US11357730B2 (en) 2006-10-25 2022-06-14 Otsuka Pharmaceutical Co., Ltd. Controlled activation ingestible identifier
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US10238604B2 (en) 2006-10-25 2019-03-26 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US9083589B2 (en) 2006-11-20 2015-07-14 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9444503B2 (en) 2006-11-20 2016-09-13 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US10441194B2 (en) 2007-02-01 2019-10-15 Proteus Digital Heal Th, Inc. Ingestible event marker systems
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US11464423B2 (en) 2007-02-14 2022-10-11 Otsuka Pharmaceutical Co., Ltd. In-body power source having high surface area electrode
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US10517506B2 (en) 2007-05-24 2019-12-31 Proteus Digital Health, Inc. Low profile antenna for in body device
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9433371B2 (en) 2007-09-25 2016-09-06 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9060708B2 (en) 2008-03-05 2015-06-23 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8810409B2 (en) 2008-03-05 2014-08-19 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8258962B2 (en) 2008-03-05 2012-09-04 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US9258035B2 (en) 2008-03-05 2016-02-09 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8542123B2 (en) 2008-03-05 2013-09-24 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US11217342B2 (en) 2008-07-08 2022-01-04 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker data framework
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US10682071B2 (en) 2008-07-08 2020-06-16 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US8721540B2 (en) 2008-08-13 2014-05-13 Proteus Digital Health, Inc. Ingestible circuitry
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
US9415010B2 (en) 2008-08-13 2016-08-16 Proteus Digital Health, Inc. Ingestible circuitry
US8036748B2 (en) 2008-11-13 2011-10-11 Proteus Biomedical, Inc. Ingestible therapy activator system and method
US8583227B2 (en) 2008-12-11 2013-11-12 Proteus Digital Health, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8055334B2 (en) 2008-12-11 2011-11-08 Proteus Biomedical, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US9149577B2 (en) 2008-12-15 2015-10-06 Proteus Digital Health, Inc. Body-associated receiver and method
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US8114021B2 (en) 2008-12-15 2012-02-14 Proteus Biomedical, Inc. Body-associated receiver and method
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US8545436B2 (en) 2008-12-15 2013-10-01 Proteus Digital Health, Inc. Body-associated receiver and method
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US9119918B2 (en) 2009-03-25 2015-09-01 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US9320455B2 (en) 2009-04-28 2016-04-26 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US10588544B2 (en) 2009-04-28 2020-03-17 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US10305544B2 (en) 2009-11-04 2019-05-28 Proteus Digital Health, Inc. System for supply chain management
US9941931B2 (en) 2009-11-04 2018-04-10 Proteus Digital Health, Inc. System for supply chain management
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US10376218B2 (en) 2010-02-01 2019-08-13 Proteus Digital Health, Inc. Data gathering system
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US10207093B2 (en) 2010-04-07 2019-02-19 Proteus Digital Health, Inc. Miniature ingestible device
US11173290B2 (en) 2010-04-07 2021-11-16 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US11504511B2 (en) 2010-11-22 2022-11-22 Otsuka Pharmaceutical Co., Ltd. Ingestible device with pharmaceutical product
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
US20120265025A1 (en) * 2011-04-13 2012-10-18 King's Metal Fiber Technologies Co., Ltd. Wearing structure for measuring physiological signal
WO2012140629A1 (en) * 2011-04-15 2012-10-18 Universidade Do Porto Polymer-based electrode for bio-signal recording
US8805470B2 (en) * 2011-07-11 2014-08-12 Covidien Lp Device with encapsulated gel
US11229378B2 (en) 2011-07-11 2022-01-25 Otsuka Pharmaceutical Co., Ltd. Communication system with enhanced partial power source and method of manufacturing same
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US20130023748A1 (en) * 2011-07-11 2013-01-24 Nellcor Puritan Bennett Llc Device with encapsulated gel
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
WO2014025353A1 (en) * 2012-08-09 2014-02-13 Northeastern University Electric field encephalography: electric field based brain signal detection and monitoring
US11083401B2 (en) 2012-08-09 2021-08-10 Northeastern University Electric field encephalography: electric field based brain signal detection and monitoring
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US11741771B2 (en) 2013-03-15 2023-08-29 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US10912480B2 (en) 2013-06-21 2021-02-09 Northeastern University Sensor system and process for measuring electric activity of the brain, including electric field encephalography
US10421658B2 (en) 2013-08-30 2019-09-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10097388B2 (en) 2013-09-20 2018-10-09 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US11102038B2 (en) 2013-09-20 2021-08-24 Otsuka Pharmaceutical Co., Ltd. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9787511B2 (en) 2013-09-20 2017-10-10 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US10498572B2 (en) 2013-09-20 2019-12-03 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US11950615B2 (en) 2014-01-21 2024-04-09 Otsuka Pharmaceutical Co., Ltd. Masticable ingestible product and communication system therefor
US11147465B2 (en) 2015-05-05 2021-10-19 Welch Allyn, Inc. Abrasive electrode
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10797758B2 (en) 2016-07-22 2020-10-06 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11793419B2 (en) 2016-10-26 2023-10-24 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers

Similar Documents

Publication Publication Date Title
US4559950A (en) Disposable biomedical and diagnostic electrode
US4196737A (en) Transcutaneous electrode construction
US4674511A (en) Medical electrode
US4838273A (en) Medical electrode
US3989035A (en) Disposable medical electrode
US4370984A (en) X-Ray transparent medical electrode
US4257424A (en) X-ray transparent medical electrode
US4067322A (en) Disposable, pre-gel body electrodes
US4715382A (en) Flat biomedical electrode with reuseable lead wire
US3993049A (en) Electrodes and materials therefor
US5465715A (en) Positive locking biomedical electrode and connector system
US4248247A (en) Low cost post-operative electrode
JPS61257628A (en) Medical electrode
US4088133A (en) Electrode for electrosurgical procedure
US3845757A (en) Biomedical monitoring electrode
US5372125A (en) Positive locking biomedical electrode and connector system
US4362165A (en) Stable gel electrode
CA1096947A (en) Non-metallic pregelled electrode
US6064901A (en) Biomedical electrode having a disposable electrode and a reusable leadwire adapter that interfaces with a standard leadwire connector
US4657023A (en) Self-adhering electrode
CA1210822A (en) Electrode with membrane separating electrolyte from terminal during storage
US5456710A (en) Vented electrode
US3942517A (en) Electrodes
US20100228113A1 (en) Improved biomedical electrode for extended patient wear featuring a tap, or snap, which is isolated from the retentional seal
US6366795B1 (en) Biomedical electrode with vital skin penetration

Legal Events

Date Code Title Description
AS Assignment

Owner name: GRAPHIC CONTROLS CORPORATION, 189 VAN RENSSALAER S

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:VAUGHAN, RAYMOND C.;DISABITO, DAVID M.;MRUK, NORBERT J.;AND OTHERS;REEL/FRAME:004229/0400

Effective date: 19831103

AS Assignment

Owner name: CITICORP INDUSTRIAL CREDIT, INC., 725 SOUTH FIGUER

Free format text: SECURITY INTEREST;ASSIGNOR:GRAPHIC CONTROLS CORPORATION, A NY CORP;REEL/FRAME:004653/0537

Effective date: 19861229

Owner name: CITIBANK, N.A.,

Free format text: SECURITY INTEREST;ASSIGNOR:GRAPHIC CONTROLS CORPORATION;REEL/FRAME:004769/0754

Effective date: 19861229

Owner name: GRAPHICS CONTROLS CORPORATION,

Free format text: LICENSE;ASSIGNOR:CITIBANK, N.A.,;REEL/FRAME:004769/0772

Effective date: 19861229

Owner name: GRAPHICS CONTROLS CORPORATION

Free format text: LICENSE;ASSIGNOR:CITIBANK, N.A.,;REEL/FRAME:004769/0772

Effective date: 19861229

Owner name: CITICORP INDUSTRIAL CREDIT, INC., CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:GRAPHIC CONTROLS CORPORATION, A NY CORP;REEL/FRAME:004653/0537

Effective date: 19861229

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: CITICORP USA, INC., CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:GRAPHIC CONTROLS CORPORATION;REEL/FRAME:006359/0192

Effective date: 19920915

AS Assignment

Owner name: GRAPHIC CONTROLS CORPORATION, NEW YORK

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CITIBANK, N.A. 399 PARK AVENUE NEW YORK, NEW YORK 10043;REEL/FRAME:006315/0765

Effective date: 19920915

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: CHEMICAL BANK ("COLLATERAL AGENT"), NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:GRAPHIC CONTROLS CORPORATION;REEL/FRAME:007709/0424

Effective date: 19950928

Owner name: GRAPHIC CONTROLS CORPORATION, NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CITICORP USA, INC.;REEL/FRAME:007709/0558

Effective date: 19950928

AS Assignment

Owner name: CHEMICAL BANK (AS COLLATERAL AGENT), NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:GRAPHIC CONTROLS CORPORATION;REEL/FRAME:007991/0697

Effective date: 19960229

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 19971224

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362